Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
4.840
+0.190 (4.09%)
Jul 14, 2025, 4:00 PM - Market closed
Olema Pharmaceuticals Market Cap
Olema Pharmaceuticals has a market cap or net worth of $331.16 million as of July 14, 2025. Its market cap has decreased by -49.49% in one year.
Market Cap
331.16M
Enterprise Value
-66.56M
1-Year Change
-49.49%
Ranking
Category
Stock Price
$4.84
Market Cap Chart
Since the IPO on November 19, 2020, Olema Pharmaceuticals's market cap has decreased from $1.79B to $331.16M, a decrease of -81.55%. That is a compound annual growth rate of -30.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 318.16M | -26.02% |
| Dec 31, 2024 | 430.06M | -43.88% |
| Dec 29, 2023 | 766.34M | 679.84% |
| Dec 30, 2022 | 98.27M | -73.58% |
| Dec 31, 2021 | 372.01M | -79.78% |
| Dec 31, 2020 | 1.84B | 2.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 716.68B |
| Johnson & Johnson | 375.54B |
| AbbVie | 336.66B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 271.63B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 230.32B |
| AstraZeneca | 218.74B |